Annual Operating Profit
-$83.51 M
+$4.23 M+4.82%
31 December 2023
Summary:
Altimmune annual operaing income is currently -$83.51 million, with the most recent change of +$4.23 million (+4.82%) on 31 December 2023. During the last 3 years, it has risen by +$2.03 million (+2.38%). ALT annual operating profit is now -25771.69% below its all-time high of $325.30 thousand, reached on 31 December 2005.ALT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$24.77 M
+$1.98 M+7.40%
30 September 2024
Summary:
Altimmune quarterly operating income is currently -$24.77 million, with the most recent change of +$1.98 million (+7.40%) on 30 September 2024. Over the past year, it has dropped by -$3.56 million (-16.80%). ALT quarterly operating profit is now -868.71% below its all-time high of $3.22 million, reached on 31 March 2015.ALT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$99.51 M
-$2.23 M-2.29%
30 September 2024
Summary:
Altimmune TTM operating income is currently -$99.51 million, with the most recent change of -$2.23 million (-2.29%) on 30 September 2024. Over the past year, it has dropped by -$16.00 million (-19.16%). ALT TTM operating profit is now -11118.71% below its all-time high of $903.10 thousand, reached on 30 June 2006.ALT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALT Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -16.8% | -19.2% |
| 3 y3 years | +2.4% | -19.7% | -16.3% |
| 5 y5 years | -308.1% | -474.4% | -386.2% |
ALT Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +4.8% | -37.5% | +7.6% | -19.2% | at low |
| 5 y | 5 years | -308.1% | +4.8% | -474.4% | +25.4% | -386.2% | at low |
| alltime | all time | <-9999.0% | +4.8% | -868.7% | +25.4% | <-9999.0% | at low |
Altimmune Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.77 M(-7.4%) | -$99.51 M(+2.3%) |
| June 2024 | - | -$26.75 M(-0.2%) | -$97.28 M(+9.9%) |
| Mar 2024 | - | -$26.79 M(+26.4%) | -$88.55 M(+6.0%) |
| Dec 2023 | -$83.51 M(-4.8%) | -$21.20 M(-5.9%) | -$83.51 M(-2.2%) |
| Sept 2023 | - | -$22.54 M(+25.2%) | -$85.40 M(-2.5%) |
| June 2023 | - | -$18.01 M(-17.2%) | -$87.61 M(-2.7%) |
| Mar 2023 | - | -$21.76 M(-5.8%) | -$90.00 M(+2.6%) |
| Dec 2022 | -$87.74 M(+2.6%) | -$23.09 M(-6.7%) | -$87.74 M(+2.8%) |
| Sept 2022 | - | -$24.75 M(+21.4%) | -$85.33 M(-9.0%) |
| June 2022 | - | -$20.39 M(+4.6%) | -$93.78 M(+4.0%) |
| Mar 2022 | - | -$19.50 M(-5.7%) | -$90.18 M(+5.4%) |
| Dec 2021 | -$85.54 M(+56.1%) | -$20.68 M(-37.7%) | -$85.54 M(+13.1%) |
| Sept 2021 | - | -$33.20 M(+97.7%) | -$75.61 M(+24.5%) |
| June 2021 | - | -$16.79 M(+13.0%) | -$60.73 M(-2.6%) |
| Mar 2021 | - | -$14.86 M(+38.2%) | -$62.35 M(+13.8%) |
| Dec 2020 | -$54.80 M(+167.8%) | -$10.75 M(-41.3%) | -$54.80 M(+13.3%) |
| Sept 2020 | - | -$18.32 M(-0.5%) | -$48.36 M(+20.0%) |
| June 2020 | - | -$18.42 M(+152.1%) | -$40.31 M(+58.4%) |
| Mar 2020 | - | -$7.31 M(+69.4%) | -$25.44 M(+24.3%) |
| Dec 2019 | -$20.46 M(+14.4%) | -$4.31 M(-58.0%) | -$20.46 M(+7.4%) |
| Sept 2019 | - | -$10.27 M(+189.3%) | -$19.05 M(+48.4%) |
| June 2019 | - | -$3.55 M(+52.5%) | -$12.83 M(-12.8%) |
| Mar 2019 | - | -$2.33 M(-19.6%) | -$14.72 M(-17.7%) |
| Dec 2018 | -$17.89 M(+11.0%) | -$2.90 M(-28.6%) | -$17.89 M(-1.9%) |
| Sept 2018 | - | -$4.06 M(-25.3%) | -$18.24 M(-1.6%) |
| June 2018 | - | -$5.44 M(-1.2%) | -$18.54 M(+8.3%) |
| Mar 2018 | - | -$5.50 M(+69.6%) | -$17.11 M(+6.1%) |
| Dec 2017 | -$16.13 M(+45.4%) | -$3.24 M(-25.4%) | -$16.13 M(+0.9%) |
| Sept 2017 | - | -$4.35 M(+8.5%) | -$15.98 M(-2.7%) |
| June 2017 | - | -$4.01 M(-11.2%) | -$16.41 M(+17.2%) |
| Mar 2017 | - | -$4.52 M(+45.8%) | -$14.01 M(+30.4%) |
| Dec 2016 | -$11.09 M(+1194.9%) | -$3.10 M(-35.3%) | -$10.74 M(+25.5%) |
| Sept 2016 | - | -$4.79 M(+198.9%) | -$8.56 M(+71.0%) |
| June 2016 | - | -$1.60 M(+27.7%) | -$5.01 M(-6.1%) |
| Mar 2016 | - | -$1.25 M(+37.3%) | -$5.33 M(+522.5%) |
| Dec 2015 | -$856.60 K | -$913.60 K(-26.1%) | -$856.70 K(-66.6%) |
| Sept 2015 | - | -$1.24 M(-35.9%) | -$2.57 M(-51.8%) |
| June 2015 | - | -$1.93 M(-159.9%) | -$5.33 M(+16.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $3.22 M(-222.8%) | -$4.57 M(-55.2%) |
| Dec 2014 | -$10.19 M(-6.0%) | -$2.62 M(-34.3%) | -$10.19 M(-19.3%) |
| Sept 2014 | - | -$4.00 M(+241.6%) | -$12.64 M(+6.7%) |
| June 2014 | - | -$1.17 M(-51.3%) | -$11.84 M(-2.6%) |
| Mar 2014 | - | -$2.40 M(-52.6%) | -$12.15 M(+12.1%) |
| Dec 2013 | -$10.84 M(+73.0%) | -$5.07 M(+58.4%) | -$10.84 M(+50.6%) |
| Sept 2013 | - | -$3.20 M(+115.9%) | -$7.20 M(+24.3%) |
| June 2013 | - | -$1.48 M(+35.8%) | -$5.79 M(+0.4%) |
| Mar 2013 | - | -$1.09 M(-23.6%) | -$5.77 M(-8.0%) |
| Dec 2012 | -$6.27 M(-46.6%) | -$1.43 M(-20.3%) | -$6.27 M(+5.8%) |
| Sept 2012 | - | -$1.79 M(+22.8%) | -$5.92 M(-17.2%) |
| June 2012 | - | -$1.46 M(-8.3%) | -$7.15 M(-18.5%) |
| Mar 2012 | - | -$1.59 M(+46.9%) | -$8.78 M(-25.2%) |
| Dec 2011 | -$11.73 M(-50.2%) | -$1.08 M(-64.2%) | -$11.73 M(-34.5%) |
| Sept 2011 | - | -$3.02 M(-1.9%) | -$17.89 M(-1.9%) |
| June 2011 | - | -$3.08 M(-32.1%) | -$18.23 M(-11.9%) |
| Mar 2011 | - | -$4.54 M(-37.3%) | -$20.69 M(-12.2%) |
| Dec 2010 | -$23.55 M(-9.3%) | -$7.25 M(+115.3%) | -$23.55 M(+5.4%) |
| Sept 2010 | - | -$3.36 M(-39.2%) | -$22.35 M(-15.7%) |
| June 2010 | - | -$5.54 M(-25.2%) | -$26.51 M(-4.4%) |
| Mar 2010 | - | -$7.41 M(+22.6%) | -$27.75 M(+7.3%) |
| Dec 2009 | -$25.97 M(+35.9%) | -$6.04 M(-19.7%) | -$25.85 M(+5.2%) |
| Sept 2009 | - | -$7.53 M(+11.2%) | -$24.58 M(+18.2%) |
| June 2009 | - | -$6.77 M(+22.8%) | -$20.80 M(+5.5%) |
| Mar 2009 | - | -$5.51 M(+15.5%) | -$19.71 M(+3.1%) |
| Dec 2008 | -$19.11 M(+15.8%) | -$4.77 M(+27.3%) | -$19.11 M(-2.8%) |
| Sept 2008 | - | -$3.75 M(-34.1%) | -$19.67 M(+0.6%) |
| June 2008 | - | -$5.68 M(+15.7%) | -$19.56 M(+68.2%) |
| Mar 2008 | - | -$4.91 M(-7.8%) | -$11.62 M(+22.8%) |
| Dec 2007 | -$16.50 M(+13.6%) | -$5.33 M(+46.5%) | -$9.46 M(+4.2%) |
| Sept 2007 | - | -$3.64 M(-261.7%) | -$9.08 M(+2.5%) |
| June 2007 | - | $2.25 M(-181.8%) | -$8.85 M(-17.7%) |
| Mar 2007 | - | -$2.75 M(-44.3%) | -$10.76 M(+38.4%) |
| Dec 2006 | -$14.53 M(-4567.8%) | -$4.94 M(+44.9%) | -$7.78 M(+191.9%) |
| Sept 2006 | - | -$3.41 M(-1109.3%) | -$2.66 M(-395.0%) |
| June 2006 | - | $337.90 K(+42.3%) | $903.10 K(+59.8%) |
| Mar 2006 | - | $237.40 K(+38.6%) | $565.20 K(+72.4%) |
| Dec 2005 | $325.30 K | $171.30 K(+9.5%) | $327.80 K(+109.5%) |
| Sept 2005 | - | $156.50 K | $156.50 K |
FAQ
- What is Altimmune annual operaing income?
- What is the all time high annual operating profit for Altimmune?
- What is Altimmune quarterly operating income?
- What is the all time high quarterly operating profit for Altimmune?
- What is Altimmune quarterly operating profit year-on-year change?
- What is Altimmune TTM operating income?
- What is the all time high TTM operating profit for Altimmune?
- What is Altimmune TTM operating profit year-on-year change?
What is Altimmune annual operaing income?
The current annual operating profit of ALT is -$83.51 M
What is the all time high annual operating profit for Altimmune?
Altimmune all-time high annual operaing income is $325.30 K
What is Altimmune quarterly operating income?
The current quarterly operating profit of ALT is -$24.77 M
What is the all time high quarterly operating profit for Altimmune?
Altimmune all-time high quarterly operating income is $3.22 M
What is Altimmune quarterly operating profit year-on-year change?
Over the past year, ALT quarterly operating income has changed by -$3.56 M (-16.80%)
What is Altimmune TTM operating income?
The current TTM operating profit of ALT is -$99.51 M
What is the all time high TTM operating profit for Altimmune?
Altimmune all-time high TTM operating income is $903.10 K
What is Altimmune TTM operating profit year-on-year change?
Over the past year, ALT TTM operating income has changed by -$16.00 M (-19.16%)